Jan 17th 2013 - Edison Investment Research today published a report on Brainjuicer (BJU.L, LSE:BJU, LON:BJU) entitled "Better Than Feared". In summary, the report says:
The year-end trading update indicates results ahead of those to which we moved after November’s warning, with revenue marginally ahead of the previous year and better-than-expected cost containment. The revenue shortfall has been predominantly in the more traditional product offering, which provides some encouragement that the more novel ‘Juicy’ products are continuing to build traction. We have left our FY13 forecasts as they stand for now, until we have a better feel for trading patterns into the new financial year. The shares are likely to mark time until the outlook clarifies.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »